Abhay Joshi Insider Trading
Get free email notifications about insider trading for Abhay Joshi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Abhay Joshi. Abhay Joshi is a EVP & Chief Technical Officer in COTHERIX INC ($CTRX) and a EVP, Chief Technical Officer in COTHERIX INC ($CTRX) and a Chief Operating Officer in Revance Therapeutics, Inc. ($RVNC) and a COO, President of R&D in Revance Therapeutics, Inc. ($RVNC) and a COO, President, R&D in Revance Therapeutics, Inc. ($RVNC).
Address: 5000 SHORELINE COURT SUITE 101 SOUTH SAN FRANCISCO 94080 CA
Companies in which Abhay Joshi is an Insider
COTHERIX INC
Trading Symbol: CTRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Abhay Joshi: EVP, Chief Technical Officer, EVP & Chief Technical Officer
Holdings: 0 shares
Latest Transaction: Jul 05 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revance Therapeutics, Inc.
Trading Symbol: RVNCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Abhay Joshi: COO, President of R&D, COO, President, R&D, Chief Operating Officer
Holdings: 128,368 shares
Current Value: $2,657,218
Latest Transaction: Mar 17 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Abhay Joshi
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 27.73 | 1,354 | 37,546 | 128,368 | 129.7 K to 128.4 K (-1.04 %) |
Feb 19 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 28.97 | 2,881 | 83,463 | 129,722 | 132.6 K to 129.7 K (-2.17 %) |
Feb 19 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 28.97 | 1,967 | 56,984 | 132,603 | 134.6 K to 132.6 K (-1.46 %) |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Option Exercise | A | 28.01 | 40,925 | 1,146,309 | 40,925 | |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Grant | A | 0.00 | 22,620 | 0 | 134,570 | 112 K to 134.6 K (+20.21 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Payment of Exercise | F | 25.14 | 7,382 | 185,583 | 111,950 | 119.3 K to 112 K (-6.19 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Joshi Abhay | COO, President, R&D | Grant | A | 0.00 | 17,500 | 0 | 119,332 | 101.8 K to 119.3 K (+17.19 %) |